StemSys

StemSys is a French biotechnology company specializing in regenerative medicine through the development of mesenchymal stem cell (MSC) therapies. The company primarily serves the veterinary market, providing advanced treatments for musculoskeletal conditions such as osteoarthritis and tendon injuries in horses and companion animals. StemSys utilizes a proprietary platform for the isolation, expansion, and rigorous characterization of stem cells to ensure high therapeutic potency and safety. By harnessing the immunomodulatory and tissue-repair capabilities of MSCs, the company offers an innovative alternative to conventional pharmacological treatments. Based in Pessac, StemSys maintains strong ties with academic research institutions to continuously refine its cell therapy protocols. Its commercialized products aim to improve the long-term recovery and quality of life for animals suffering from chronic inflammatory disorders.